Secure Independent Evaluation and Adjudication of Complex Clinical Trial Endpoints

Whether you need assessment from one medical expert or an endpoint adjudication committee (EAC), Advarra’s worldwide network of medical and clinical research professionals have the experience to independently assess and advise on clinical drug and device trial endpoints.

• Accelerates study startup
• Improves independence
• Has unmatched experience
• Optimizes compliance

Download this info sheet to learn more about Advarra’s EAC services.